Updates in the Diagnosis, Imaging, and Treatment of Retinal and Macular Diseases

Dear Colleagues,

Retinal and macular diseases, including age-related macular degeneration, diabetic retinopathy and inherited retinal disorders, remain leading causes of visual impairment and blindness worldwide. In recent years, remarkable advances in diagnostic imaging, artificial intelligence (AI) and novel therapeutic approaches have revolutionized our understanding and management of these conditions.

This Special Issue aims to highlight recent progress and emerging trends in the clinical diagnosis, imaging technologies and treatment strategies for retinal and macular diseases. We particularly welcome submissions that explore AI-assisted image analysis, deep learning–based diagnostic systems and multimodal imaging techniques such as OCT, OCTA, fundus autofluorescence and adaptive optics.

In addition, contributions focusing on novel pharmacologic treatments, surgical innovations, gene and cell therapies as well as personalized or precision medicine approaches are highly encouraged. Reviews, original research articles and clinical case studies that provide new insights into patient management and disease outcomes are also welcome.

Through this Special Issue, we aim to provide a comprehensive update on how digital technologies and translational research are reshaping clinical ophthalmology, ultimately improving the prevention, early detection and treatment of retinal and macular diseases.

Prof. Dr. Makoto Inoue
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.